CG200745

· CrystalGenomics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CG200745, covering 2019-06-17 to 2019-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer [Phase 1, Phase 2]

See pricing